6 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 4–6 mL QID or 1– ... antifungals are required ... #IDSA #Prevention ... opportunistic #infections
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Toxic Megacolon, Shock ... A/B release → mucosal ... Epidemiology: • #1 ... can be community-acquired ... 10 mg/kg IV x 1
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
clinical forms: 1) ... Fluconazole SYSTEMIC CANDIDIASIS ... fever • Septic shock ... blood cultures Candidiasis ... colonization Candidiasis
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
the secondary or acquired ... cytokines, such as IL-1 ... to purpura to mucosal ... SLE], AOSD) • Infection ... Treatment: • Corticosteroids
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
may precede the neurologic ... /Sepsis/Shock, Autoimmune ... PRES Diagnosis: 1. ... Diagnosis: • Infection ... epilepticus Treatment
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... and cauda equina TREATMENT ... ventilation is required ... Guillain #Barre #Syndrome ... diagnosis #management #neurology